Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SG301 SC in Systemic Lupus Erythematosus
NCT07447986Phase 2Recruiting
- Sponsor
- Shangjian Bio
- Start
- Mar 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 2 trial of SG301 in systemic lupus erythematosus (SLE), sponsored by Shangjian Bio. Started Mar 2026; status: recruiting.
02
Drugs
SG301
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT07447986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07447986.